Correlation Between X4 Pharmaceuticals and Merus BV
Can any of the company-specific risk be diversified away by investing in both X4 Pharmaceuticals and Merus BV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining X4 Pharmaceuticals and Merus BV into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between X4 Pharmaceuticals and Merus BV, you can compare the effects of market volatilities on X4 Pharmaceuticals and Merus BV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in X4 Pharmaceuticals with a short position of Merus BV. Check out your portfolio center. Please also check ongoing floating volatility patterns of X4 Pharmaceuticals and Merus BV.
Diversification Opportunities for X4 Pharmaceuticals and Merus BV
0.34 | Correlation Coefficient |
Weak diversification
The 3 months correlation between XFOR and Merus is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding X4 Pharmaceuticals and Merus BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Merus BV and X4 Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on X4 Pharmaceuticals are associated (or correlated) with Merus BV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Merus BV has no effect on the direction of X4 Pharmaceuticals i.e., X4 Pharmaceuticals and Merus BV go up and down completely randomly.
Pair Corralation between X4 Pharmaceuticals and Merus BV
Given the investment horizon of 90 days X4 Pharmaceuticals is expected to under-perform the Merus BV. In addition to that, X4 Pharmaceuticals is 2.01 times more volatile than Merus BV. It trades about -0.03 of its total potential returns per unit of risk. Merus BV is currently generating about 0.06 per unit of volatility. If you would invest 2,673 in Merus BV on August 28, 2024 and sell it today you would earn a total of 1,866 from holding Merus BV or generate 69.81% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
X4 Pharmaceuticals vs. Merus BV
Performance |
| Timeline |
| X4 Pharmaceuticals |
| Merus BV |
X4 Pharmaceuticals and Merus BV Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with X4 Pharmaceuticals and Merus BV
The main advantage of trading using opposite X4 Pharmaceuticals and Merus BV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if X4 Pharmaceuticals position performs unexpectedly, Merus BV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Merus BV will offset losses from the drop in Merus BV's long position.| X4 Pharmaceuticals vs. Eliem Therapeutics | X4 Pharmaceuticals vs. HCW Biologics | X4 Pharmaceuticals vs. Scpharmaceuticals | X4 Pharmaceuticals vs. Milestone Pharmaceuticals |
| Merus BV vs. Anebulo Pharmaceuticals | Merus BV vs. Adagene | Merus BV vs. Acrivon Therapeutics, Common | Merus BV vs. AnaptysBio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |